These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25968627)

  • 1. Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
    Sperry BW; Oldan JD; Hsich EM; Reynolds JP; Tamarappoo BK
    J Nucl Cardiol; 2015 Aug; 22(4):840-4. PubMed ID: 25968627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
    Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
    J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of myocardial washout of
    Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
    Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    Kherajani P; Farag AA; Morgan WS; Hage FG; Bhambhvani P
    J Nucl Cardiol; 2023 Dec; 30(6):2525-2530. PubMed ID: 37524998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
    Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
    Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
    Peretto G; Busnardo E; Ferro P; Palmisano A; Vignale D; Esposito A; De Luca G; Campochiaro C; Sartorelli S; De Gaspari M; Rizzo S; Dagna L; Basso C; Gianolli L; Della Bella P; Sala S
    JACC Cardiovasc Imaging; 2022 Oct; 15(10):1771-1780. PubMed ID: 36202457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
    Campisi R; Merani MF; Rodríguez MI
    Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
    Hanneman K; Kadoch M; Guo HH; Jamali M; Quon A; Iagaru A; Herfkens R
    Clin Nucl Med; 2017 Jul; 42(7):e328-e334. PubMed ID: 28418949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential novel imaging targets of inflammation in cardiac sarcoidosis.
    Park J; Young BD; Miller EJ
    J Nucl Cardiol; 2022 Oct; 29(5):2171-2187. PubMed ID: 34734365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
    Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
    Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of FDG PET/CT in inflammatory cardiovascular disease.
    James OG; Christensen JD; Wong TZ; Borges-Neto S; Koweek LM
    Radiographics; 2011; 31(5):1271-86. PubMed ID: 21918044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.
    Miyagawa M; Yokoyama R; Nishiyama Y; Ogimoto A; Higaki J; Mochizuki T
    Circ J; 2014; 78(6):1302-10. PubMed ID: 24817762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
    Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
    J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    Lucinian YA; Martineau P; Poenaru R; Tremblay-Gravel M; Cadrin-Tourigny J; Harel F; Pelletier-Galarneau M
    J Nucl Cardiol; 2023 Dec; 30(6):2490-2500. PubMed ID: 37258950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.